Related Experiment Video

Updated: May 21, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Chemotherapeutic failure: resistance or insensitivity?

A S Braverman1

  • 1State University of New York-Health Science Center, Brooklyn.

Annals of Internal Medicine
|April 15, 1993
PubMed

Insights

Traditional cancer therapies like chemotherapy show limited success in epithelial neoplasms, suggesting insensitivity, not resistance. Future cancer treatment may involve modulating cell physiology through molecular biology advancements, like differentiation induction.

Area of Science:

  • Oncology
  • Cancer Biology
  • Molecular Medicine

Background:

  • Chemotherapy is effective for immunocyte and germ cell neoplasms but may not generalize to other tumors.
  • Limited success in treating epithelial neoplasms might stem from cellular insensitivity rather than drug resistance.
  • Previous attempts to overcome drug resistance and the role of immune surveillance in cancer have yielded limited evidence.

Purpose of the Study:

  • To evaluate the validity of generalizing chemotherapy success from specific neoplasms to others.
  • To explore reasons for limited success in treating epithelial neoplasms.
  • To assess the potential of novel therapeutic strategies based on molecular biology.

Main Methods:

  • Review of existing data on chemotherapy, drug resistance, and immunotherapy outcomes.
  • Analysis of the role of immune surveillance in neoplasm pathogenesis.
  • Examination of emerging molecular biology insights into neoplastic cell physiology.

Main Results:

  • Generalizing chemotherapy efficacy from curable neoplasms to others may be invalid.
  • Epithelial neoplasms might be insensitive to cytotoxic drugs, not resistant.
  • Advanced immunotherapies function as nonspecific cell-killing methods.
  • Molecular biology is rapidly elucidating cancer cell mechanisms.
  • Differentiation induction has shown success in specific leukemias and carcinomas.

Conclusions:

  • Further investigation of immunologic and cytotoxic drug therapies is warranted on a smaller scale.
  • Modulating cancer cell physiology via molecular biology offers a promising therapeutic avenue.
  • Differentiation induction represents a successful example of molecularly targeted cancer therapy.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...